Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update

Author's Avatar
May 15, 2023

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced first quarter 2023 results and provided a business update.